|  | 
|  | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhaseDiscontinued | 
| First Approval Ctry. / Loc.- | 
| First Approval Date20 Jan 1800 | 
|  | 
|  | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhaseDiscontinued | 
| First Approval Ctry. / Loc.- | 
| First Approval Date20 Jan 1800 | 
|  | 
|  | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhaseDiscontinued | 
| First Approval Ctry. / Loc.- | 
| First Approval Date20 Jan 1800 | 
100 Clinical Results associated with SYNGAP1 x FTase
100 Translational Medicine associated with SYNGAP1 x FTase
0  Patents (Medical) associated with SYNGAP1 x FTase